Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05101629
Title Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Augsburg Augsburg 86156 Germany Details
Charité-Universitätsmedizin Berlin Berlin 13353 Germany Details
Krankenhaus Nordwest Frankfurt 60488 Germany Details
Universitätsklinikum Gießen und Marburg Gießen 35392 Germany Details
Universitätsmedizin Göttingen Göttingen 37075 Germany Details
Medizinische Hochschule Hannover Hannover 30625 Germany Details
Universitätsklinikum Jena Jena 07747 Germany Details
Universitätsklinikum Giessen und Marburg Marburg 35043 Germany Details
Klinikum der Universität München München 81377 Germany Details
Klinikum rechts der Isar der Technischen Universität München München 81675 Germany Details
Klinikum Nürnberg Nürnberg 90419 Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field